对阿尔茨海默氏氏症进行新的血液测试,达到91%的准确度,可以改变诊断和治疗。 New blood tests for Alzheimer's, up to 91% accurate, could transform diagnosis and treatment.

阿尔茨海默氏协会报告说,新的血液测试可以使阿尔茨海默氏病的诊断发生革命性变化,其精确度高达91%,使其比目前的方法更容易,而且不那么具有侵入性。 The Alzheimer's Association reports that new blood tests could revolutionize Alzheimer's diagnosis, with up to 91% accuracy, making it easier and less invasive than current methods. 早期诊断可导致更好的治疗结果,使用林业发展局批准的新的药物,如Leqembi和Kisunla。 Early diagnosis could lead to better treatment outcomes with new FDA-approved drugs like Leqembi and Kisunla. 报告还强调要解决饮食和运动等可改变的风险因素,以减少老年痴呆症的风险,因为近一半的痴呆症是可以预防的。 The report also emphasizes addressing modifiable risk factors, such as diet and exercise, to reduce Alzheimer's risk, as nearly half of all dementias could be preventable. 该协会启动了ALZ-NET,这是一个全国性的跟踪系统,以监测新治疗的长期影响。 The association launched ALZ-NET, a nationwide tracking system to monitor the long-term effects of new treatments.